- Home
- IRON vs FLNG Comparison
IRON vs FLNG Comparison
Compare IRON & FLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- FLNG
- Stock Information
- Founded
- IRON 2017
- FLNG 2006
- Country
- IRON United States
- FLNG Bermuda
- Employees
- IRON N/A
- FLNG N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- FLNG Marine Transportation
- Sector
- IRON Health Care
- FLNG Consumer Discretionary
- Exchange
- IRON Nasdaq
- FLNG Nasdaq
- Market Cap
- IRON 1.4B
- FLNG 1.3B
- IPO Year
- IRON N/A
- FLNG N/A
- Fundamental
- Price
- IRON $46.68
- FLNG $23.91
- Analyst Decision
- IRON Strong Buy
- FLNG Hold
- Analyst Count
- IRON 9
- FLNG 1
- Target Price
- IRON $93.89
- FLNG $23.00
- AVG Volume (30 Days)
- IRON 354.8K
- FLNG 315.9K
- Earning Date
- IRON 05-07-2025
- FLNG 05-21-2025
- Dividend Yield
- IRON N/A
- FLNG 12.55%
- EPS Growth
- IRON N/A
- FLNG N/A
- EPS
- IRON N/A
- FLNG 1.91
- Revenue
- IRON N/A
- FLNG $354,551,000.00
- Revenue This Year
- IRON N/A
- FLNG N/A
- Revenue Next Year
- IRON N/A
- FLNG $3.64
- P/E Ratio
- IRON N/A
- FLNG $12.51
- Revenue Growth
- IRON N/A
- FLNG N/A
- 52 Week Low
- IRON $30.82
- FLNG $19.46
- 52 Week High
- IRON $68.73
- FLNG $29.18
- Technical
- Relative Strength Index (RSI)
- IRON 49.90
- FLNG 53.17
- Support Level
- IRON $44.85
- FLNG $22.24
- Resistance Level
- IRON $47.36
- FLNG $24.25
- Average True Range (ATR)
- IRON 2.23
- FLNG 0.60
- MACD
- IRON -0.12
- FLNG -0.08
- Stochastic Oscillator
- IRON 37.58
- FLNG 56.00
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About FLNG FLEX LNG Ltd.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with tonnage offering advantages in form of reduced fuel consumption and lowered boil-off rates.